Daniel M. Bendheim
CIK: 0001601576
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
PHIBRO ANIMAL HEALTH CORP
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Aug 6, 2026PAHC
PHIBRO ANIMAL HEALTH CORP
Award(A)Direct11.7K shares- - Aug 4, 2026PAHC
PHIBRO ANIMAL HEALTH CORP
Other(J)Direct486 shares at avg. $36.60$18K - Jul 1, 2026PAHC
PHIBRO ANIMAL HEALTH CORP
Award(A)DirectPerformance Stock Units
300K shares- - Aug 15, 2025PAHC
PHIBRO ANIMAL HEALTH CORP
Award(A)Direct4K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 6, 2026 | PAHC PHIBRO ANIMAL HEALTH CORP | Award(A) | 11,699 | - | $0 | Direct |
| Aug 4, 2026 | PAHC PHIBRO ANIMAL HEALTH CORP | Other(J) | 486 | $36.60 | $17,787 | Direct |
| Jul 1, 2026 | PAHC PHIBRO ANIMAL HEALTH CORP | Award(A) Performance Stock Units | 300,000 | - | - | Direct |
| Aug 15, 2025 | PAHC PHIBRO ANIMAL HEALTH CORP | Award(A) | 3,964 | - | - | Direct |
1-4 of 4 transactions
About Bendheim Daniel M
Bendheim Daniel M (SEC CIK 0001601576) files insider reports with the SEC as President and CEO of PHIBRO ANIMAL HEALTH CORP (PAHC).
Signal8 holds 4 ownership filings by Bendheim Daniel M, all Form 4s, filed between Aug 19, 2025 and Aug 10, 2026. Those filings report 4 transactions, from Aug 15, 2025 to Aug 6, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Bendheim Daniel M's filings is in TEANECK, NJ.
Recent filings by Bendheim Daniel M
Other insiders filing for PHIBRO ANIMAL HEALTH CORP (PAHC)
- David Glenn, Chief Financial Officer
- Miller Larry Lee, Chief Operating Officer
- Rodriguez Patrick, VP Finance and Treasurer
- BENDHEIM Jonathan, Director
- Weinstein Judith
- BENDHEIM JACK, Executive Chairman